After initially being postponed, the third bellwether case for the Bard
Avaulta transvaginal mesh trials is finally set to begin on May 19
th. In addition, the discovery process for an additional 200 cases has been
initiated. This is good news for the tens of thousands of women who are
still suffering after being implanted with a transvaginal mesh product.
Avaulta is just one of the several brands of transvaginal mesh products
that are used to treat pelvic organ prolapse (PIP) and stress urinary
incontinence in women. C.R. Bard manufactures Avaulta, as well as FasLata
Allograft, Pelvicol, and PelviSoft Biomesh. Other manufacturers include
Johnson & Johnson, Boston Scientific, and American Medical Systems.
All of these manufacturers have been implicated in more than 50,000 lawsuits
that have already been filed in a consolidated MDL.
This bellwether trial is the third case that will not only help to shape
the rest of transvaginal litigation, but also help pave the way for the
thousands of other women who have been injured and who are currently waiting
for compensation. The first of the Bard bellwether trials began last July
and resulted in a $2 million jury award.
Dangers of Transvaginal Mesh Products
Once highly praised as a non-invasive way to treat pelvic organ prolapse
and stress urinary incontinence, transvaginal mesh implants are now considered
a serious health risk. After receiving numerous complaints, the FDA began
to grow concerned. In 2008, the FDA sent a warning to doctors who were
performing these procedures and warned them to notify their patients of
the risks and in 2011, the FDA issued a warning that the risks of using
these products outweighed any of their benefits.
Some of the more serious complications that women have suffered, include:
- Serious infections
- Organ perforation
- Internal bleeding and damage
- Return of stress urinary incontinence
- Return of pelvic organ prolapse
- Protrusion of mesh through vaginal wall
- Pain with intercourse
- Erosion of the vaginal wall
- Skin breakage
- And more
At least 7 deaths have been linked to the use of transvaginal mesh implants
and thousands more have been injured.
C.R. Bard is not the only medical device manufacturer in hot water over
their transvaginal mesh product. Johnson & Johnson is currently facing
more than 12,000 lawsuits over their Ethicon mesh implant alone. Other
manufacturers include, American Medical Systems, Boston Scientific Corp,
National Transvaginal Mesh Litigation Lawyers
If you or someone you love has suffered medical complications after receiving
a transvaginal mesh implant, you may be able to file a lawsuit. To learn
more about your rights and legal options, call the Philadelphia dangerous
medical device lawyers at Golomb & Honik, P.C. today.